Ossio Ltd.

OSSIO Inc. manufactures OSSIO fiber®, a proprietary bio-integrative orthopedic implant material engineered from natural minerals identical to bone composition. Unlike permanent metal hardware, OSSIO fiber® implants integrate fully into native bone over 18–24 months and are naturally resorbed, leaving only healthy bone behind. The material provides strength comparable to cortical bone while promoting predictable bio-integration and eliminating long-term complications associated with permanent implants, including allergic reactions, stress shielding, and the need for revision surgery. OSSIO fiber® is indicated for foot and ankle orthopedic procedures, including hammertoe correction and other fixation applications. The company operates research, manufacturing, and quality assurance facilities in Caesarea, Israel, and maintains commercial headquarters in Woburn, Massachusetts. Clinical data demonstrates 100% patient satisfaction in hammertoe studies with high functional outcomes. OSSIO fiber® implants meet FDA regulatory standards for orthopedic devices and are positioned as a transformative alternative to conventional titanium and stainless steel hardware in podiatric and orthopedic surgery.